ArticlePloS one2026
Exploratory research on drugs after lung surgery based on real-world data from the FDA adverse event reporting system database.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundsLung surgery is the most common surgery in thoracic surgery, but postoperative dyspnea, cough, palpitations, and chest pain seriously affect the quality of life of patients and hinder their postoperative recovery.
methodsTo reveal the potential correlation between drugs and adverse events, we used disproportionation analysis to calculate the ROR and PRR values of the top 30 reported cases of dyspnea, cough, palpitations, and chest pain, respectively. In addition, we defined high and medium ROR signaling drugs after lung surgery by generating Venn diagram and calculated the PRR of all drugs used to treat pulmonary hypertension to explore the correlation between pulmonary arterial hypertension drugs and these four symptoms.
resultsWe identified the top 30 drugs that are most related to dyspnea, cough, palpitations, and chest pain, and defined 4 high ROR signaling drugs after lung surgery, and 10 medium ROR signaling drugs after lung surgery. Among them, 3 high ROR signaling drugs are drugs for treating pulmonary hypertension (PH). Subsequently, further analysis revealed that it is the basic drug attribute of treating PH that can easily cause these four common symptoms after lung surgery.
conclusionOur study provides a list of high and medium ROR signaling drugs drugs for postoperative patients with lung surgery and clarifies the potential correlation between the properties of drugs for treating pulmonary arterial hypertension and dyspnea, cough, palpitations, and chest pain, providing a theoretical basis for the medication of postoperative patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.